In contrast, other groups observed that CLL patients harboring NOTCH1 mutations in a small portion of the leukemic population show a shorter time to first treatment and reduced overall survival similar to that of clonally mutated CLL (72, 79). This evidence concerns the gene NOTCH1 and B-cell chronic lymphocytic leukemia.